Significance of immunocytochemical expression of E-cadherin, N-cadherin and CD44 in serous effusions using liquid-based cytology

Acta Cytologica

Volumn 49, Issue 1, 2005, Pages 11-16

  Malle, Despoina ^a,b   Valeri, Rosaria Maria ^a,b   Photiou, Charicleia ^a,b   Kaplanis, Konstantin ^a,b   Andreadis, Charalampos ^a,b   Tsavdaridis, Dimitrios ^a,b   Destouni, Charicleia ^a,b  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b Department of Cytopathology ^*  (Greece)

Author keywords

CD44 antigen; E cadherin; Immunocytochemistry; Liquid based cytology; N cadherin; ThinPrep

Indexed keywords

HERMES ANTIGEN; NERVE CELL ADHESION MOLECULE; UVOMORULIN;

ADENOCARCINOMA; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTODIAGNOSIS; EFFUSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MESOTHELIOMA; MESOTHELIUM CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 12544257569     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326088     Document Type: Article

References (20)

1. Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindan J: Immunocytochemistry in the differential diagnosis of serous effusions: A comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Cancer 2001;93:68-72
2. Hedrick L, Cho KR, Vogelstein B: Cell adhesion molecules as tumour suppressors. Trends Cell Biol 1993;3:36-39
3. Similar A, Fetsch P, Mehta D, Zakowski M, Abati A: E-cadherin, N-cadherin and calretinin in pleural effusions: The good, the bad, the worthless. Diagn Cytopathol 1999;20:125-130
4. Peralta Soler KA, Knudsen A, Tecson-Meguel FX, McBrearty AC, Han H, Salazar H: Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol 1997;28:734-739
5. Peralta Soler A, Knudsen KA, Jaurand MD, Johnson KR, Wheelock MJ, Klein-Szanto AJ, Salazar H: The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Hum Pathol 1995;26:1363-1369
6. Berner HS, Davidson B, Berner A, Risberg B, Kristensen GB, Trope CG, Van de Putte G, Nesland JM: Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma: Diagnostic and prognostic implications. Clin Exp Metastasis 2000;18:197-202
7. Berner HS, Davidson B, Berner A, Resberg B, Nesland JM: Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions. Virchows Arch 2000;436:330-335
8. Chhieng DC, Yee H, Cangiarella JF, Symmans WF, Cohen JM: Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings. Cancer 2000;90:299-306
9. Han AC, Peralta-Soler A, Knudsen KA, Wheelock MJ, Johnson KR, Salazar H: Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Hum Pathol 1997;28:641-645
10. Leers MPG, Aarts MMJ, Theunissen PHMH: E-cadherin and calretinin: A useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma. Histopathology 1998;32:209-216
11. Schofield K, Daquila T, Rimm DL: The cell adhesion melecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids. Cancer 1997;81:293-298
12. Kitazume H, Kitamura K, Mukai K, Inayama Y, Kawano N, Nakamura N, Sano J, Mitsui K, Yoshida S, Nakatani Y: Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma and adenocarcinoma: Utility of combined E-cadherin and calretinin immunostaining. Cancer Cytopathol 2000;90:55-60
13. Davies BR, Worsley SD, Ponder BA: Expression of E-cadherin, a catenin and b-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology 1998;32:69-80
14. Hashimoto M, Niwa O, Nitta Y, Takeichi M, Yokoro K: Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn J Cancer Res 1989;80:459-463
15. Peluso JJ: N-cadherin mediated cell contact regulates ovarian surface epithelial cell survival. Biol Signals Recept 2000;9:115-121
16. Peralta Soler A, Knudsen KA, Tecson-Minguel A, McBreasty FX, Hay AC, Salazar H: Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol 1997;28:734-739
17. Nagae Y, Kameyama K, Yokoyama M, Naito Z, Yamada N, Maeda S, Asano G, Sugisake Y, Tanaka S: Expression of E-cadherin catenin and C-erb B-2 gene products in invasive ductal-type breast carcinomas. J Nippon Med Sch 2002;69:165-171
18. Berx G, Cleton Jansen AM, Strumane K, De Leeuw WJ, Nollet F, Van Roy F, Cornelisse C: E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996;13:1919-1925
19. Attanoos RL, Webb R, Gibbs AR: CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma. Histopathology 1997;30:260-263
20. Ordonez NG: Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and non-pulmonary adenocarcinoma. Am J Surg Pathol 2000;24:598-606